health care consulting firm
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2025 | ALLIANCE FOR A STRONGER FDA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2025 | ARGENTUM MEDICAL DBA BRAVIDA MEDICAL |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | — | |
| 2025 | A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | — | |
| 2025 | PARTNER THERAPEUTICS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2025 | COALITION TO STOP FLU |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$36,000 | — | |
| 2025 | RESOLVE TO SAVE LIVES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$25,000 | — | |
| 2025 | ARTHROSCOPY ASSOCIATION OF NORTH AMERICA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | — | |
| 2025 | SEQIRUS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2025 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2025 | BAVARIAN NORDIC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| BAVARIAN NORDIC | 39 | $1,430,000 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 38 | $915,000 |
| SEQIRUS | 37 | $1,595,000 |
| ARTHROSCOPY ASSOCIATION OF NORTH AMERICA | 37 | $967,500 |
| BAKER DONELSON (ON BEHALF OF THE DEANS NURSING POLICY COALITION) | 32 | $80,000 |
| RESOLVE TO SAVE LIVES | 30 | $900,000 |
| COALITION TO STOP FLU | 25 | $814,000 |
| PARTNER THERAPEUTICS | 20 | $855,000 |
| A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) | 19 | $367,000 |
| HELIX OPCO, LLC | 15 | $504,000 |
| ORGANON & CO | 12 | $330,000 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 10 | $360,000 |
| ARGENTUM MEDICAL DBA BRAVIDA MEDICAL | 10 | $360,000 |
| MERCK & CO., INC. | 10 | $324,000 |
| HELEN KELLER NATIONAL CENTER | 9 | $70,000 |
| NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION | 6 | $225,000 |
| ALLIANCE FOR A STRONGER FDA | 6 | $225,000 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH | 5 | $135,000 |
| GLOBAL HEALTH INVESTMENT CORPORATION | 3 | $80,000 |
| AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 3 | $50,000 |
| Name | Disclosed Prior Position |
|---|---|
| MARY MOODY JOHNSON | U.S. Senate Health, Education, Labor and Pensions |
| SARA LOVE RAWLINGS | U.S. Senate Committee on Appropriations |
| JORDAN TENENBAUM |